TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells-Reference-Cited by-同舟云学术

TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells

Published:2016-03-22 Issue:18 Volume:27 Page:185101
ISSN:0957-4484
Container-title:Nanotechnology
language:
Short-container-title:Nanotechnology

Author:

De Miguel Diego,Gallego-Lleyda Ana,Ayuso José María,Erviti-Ardanaz Sandra,Pazo-Cid Roberto,del Agua Celia,Fernández Luis José,Ochoa Ignacio^ORCID,Anel Alberto,Martinez-Lostao Luis

Funder

MICROANGIOTHECAN (IO)

CIBER-IMIBIC

Ministerio de Ciencia e Innovación

Instituto de Salud Carlos III

Ministerio de Economía y Competitividad

Publisher

IOP Publishing

Subject

Electrical and Electronic Engineering,Mechanical Engineering,Mechanics of Materials,General Materials Science,General Chemistry,Bioengineering

Link

http://stacks.iop.org/0957-4484/27/i=18/a=185101/pdf

Reference48 articles.

1. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists

2. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity

3. SU-8 Based Microdevices to Study Self-Induced Chemotaxis in 3D Microenvironments

4. Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis

5. State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer;Biomaterials;2025-01

2. Lipid Nanoparticles in Lung Cancer Therapy;Pharmaceutics;2024-05-10

3. Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death;Apoptosis;2023-05-15

4. Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer;Pharmaceutics;2023-05-10

5. Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors;Molecular Pharmaceutics;2023-05-03